[go: up one dir, main page]

UY27608A1 - Formas cristalinas hidratadas de atorvastatina forma ii y forma iv. - Google Patents

Formas cristalinas hidratadas de atorvastatina forma ii y forma iv.

Info

Publication number
UY27608A1
UY27608A1 UY27608A UY27608A UY27608A1 UY 27608 A1 UY27608 A1 UY 27608A1 UY 27608 A UY27608 A UY 27608A UY 27608 A UY27608 A UY 27608A UY 27608 A1 UY27608 A1 UY 27608A1
Authority
UY
Uruguay
Prior art keywords
atorvastatin
crystal forms
hydrated crystal
heptanoic
hypercholesterolemia
Prior art date
Application number
UY27608A
Other languages
English (en)
Inventor
Briggs Christopher
Jennings Rex Allen
Rpbert A Wade
Hara-Sawa Kikuko
Ichikawa Shigeru
Monohara Kazuo
Nakaguwa Shinsuke
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to UY27608A priority Critical patent/UY27608A1/es
Publication of UY27608A1 publication Critical patent/UY27608A1/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen formas cristalinas de ácido (R-(R*, R*))1-2-(4-fluorofenil)-B, O-dihidroxi-5-(1-metiletil)-3-fenil-4-((fenilamino)carbonil)-1H-pirrol-1-heptanoico sal de hemi calcio, denominadas Forma II y Forma IV, caracterizadas por su difracción de polvo en rayos X y/o por su RMN de estado sólido y composiciones farmacéuticas, que sirven como agentes para tratar la hiperlipidemia e hipercolesterolemia.
UY27608A 2002-12-30 2002-12-30 Formas cristalinas hidratadas de atorvastatina forma ii y forma iv. UY27608A1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27608A UY27608A1 (es) 2002-12-30 2002-12-30 Formas cristalinas hidratadas de atorvastatina forma ii y forma iv.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27608A UY27608A1 (es) 2002-12-30 2002-12-30 Formas cristalinas hidratadas de atorvastatina forma ii y forma iv.

Publications (1)

Publication Number Publication Date
UY27608A1 true UY27608A1 (es) 2004-07-30

Family

ID=38812726

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27608A UY27608A1 (es) 2002-12-30 2002-12-30 Formas cristalinas hidratadas de atorvastatina forma ii y forma iv.

Country Status (1)

Country Link
UY (1) UY27608A1 (es)

Similar Documents

Publication Publication Date Title
AR003458A1 (es) Forma cristalina de atorvastatina o hidrato de la misma y composicion farmaceutica que la comprende.
UY27359A1 (es) Formas cristalinas de la sal de calcio del ácido (r-(r', r'))-2(4fluorofenil)-beta, omega-dihidroxi-5-(1-metiletil)-3-fenil-4-((fenilamino)carbonil)-1h-pirrol-1-heptanoico (2:1)
BR9610567A (pt) Hemi sal cálcio de ácido (R(R*,R*)-2-(4-fluorofenil)-beta-delta-dihidróxi-5-(1-metil-etil)-3-fenil-4-((fenilamino)carbonil)-1H-pirrol-1-heptanóico(atorvastatína) de forma cristalina iii
MXPA04000889A (es) Formas cristalinas vi y vii de atorvastatina calcica.
WO2005105738A3 (en) Salt forms of atorvastatin
UY27608A1 (es) Formas cristalinas hidratadas de atorvastatina forma ii y forma iv.
DE602006019710D1 (de) Magnesiumsalze von hmg-coa-reduktase-hemmern
BRPI0414457A (pt) formas cristalinas do ácido [r-(r*,r*)]-2-(4-fluorofenil)-beta, delta-dihidróxi-5-(1-metiletil)-3-fenil-4-[(fenilamino)-c arbonil]-1h-pirrol-1-heptanóico
TW200738624A (en) Novel forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium
WO2006011041A3 (en) Crystalline forms of (r-(r*))-2-(4-fluorophenyl)-beta, gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-1-hept anoic acid calcium salt (2:1)
ECSP961823A (es) Acido cristalino [r- (r*, r*)]- 2- (4- fluorofenil) -b, 8 -dihidroxi- 5- (1- metiletil) - 3 - fenil- 4- [(fenilamino) carbonil]- 1h- pirrol - 1- heptanoico sal de calcio (2.1)
BRPI0511508A (pt) formas de sais de atorvastatina, composição farmacêutica e processo
CA2521833A1 (en) Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin)
ECSP961824A (es) Forma iii cristalina de sal de calcio de acido [r-(r*,r*)- 2-(4 fluorofenil) - b, g- dihidroxi-5-(1 metiletil) - 3- fenil - 4-[(fenilamino) carbonil]- 1h -pirrol - 1- heptanoico (2.1)
HN2002000159A (es) Formas cristalinas de la sal de calcio del acido [r-(r*,r*]]-2-(4-fluorofenil) - b, o - dihidroxi - 5 - (1 - metiletil) - 3 fenil - 4 - (fenil amino) carbonil] - 1h - pirrol - 1 - heptanoicp (2:1)
IS7019A (is) Kristallaform af 'R-(R*,R*)!-2-(4-flúorfenýl)-beta, delta-díhýdroxý-5-(1-metýletýl)-3-fenýl-4-'fenýlamínó)karbónýl!-1H-pýrról-1-heptansýru kalsíum salt (2:1) (atorvastatín)

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20170116